IP Library Granted Patent US 11,986,280
Granted Patent B2
US 11,986,280 · App. 17/208,832 · Granted May 21, 2024

Systems and methods for vascular diagnosis using blood flow magnitude and/or direction

Inventors: Leo J. Grady (Darien, CT); Charles A. Taylor (Atherton, CA)
Assignee: HeartFlow, Inc.
A61B5/026A61B5/02028A61B5/7246A61B5/7275A61B5/7278A61B5/74A61B8/06A61B8/0891A61B34/10G16H50/20G16H50/50A61B5/742A61B8/488
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,986,280
App. No.
17/208,832
Granted
May 21, 2024
Kind
B2
Abstract

Systems and methods are disclosed for diagnosing and treatment planning for vascular steal syndromes and retrograde flow, One method includes receiving a reference blood flow direction at a location in a reference vasculature; determining a patient-related brood flow direction at a location in a patient's vasculature corresponding to the location in the reference vasculature; determining a difference in direction, between the reference blood flow direction of the reference vasculature and the patient-related blood flow direction of the patient's vasculature; and generating a representation of the location in the patient's vasculature associated with the difference in direction between the reference blood flow direction and the patient-related blood flow direction, or generating a treatment recommendation for the patient's vasculature based on the difference in direction between the reference blood flow direction and the patient-related blood flow direction.

Claims (58)

1. A computer-implemented method of determining blood flow deviation in a patient's vasculature, the method comprising:

receiving a patient-specific anatomic model of at least a portion of a patient's vasculature;

modifying the patient-specific anatomic model to create a plurality of modified models, wherein each of the plurality of modified models includes a respective proposed treatment of a plurality of proposed treatments for a condition other than vascular steal syndrome;

receiving (1) a first reference blood flow magnitude indicating an amount of blood flow at a predetermined first location of a population-based reference vasculature, and (2) a second reference blood flow magnitude indicating an amount of blood flow at a predetermined second location of the population-based reference vasculature;

calculating a reference relative blood flow magnitude by comparing the first reference blood flow magnitude to the second reference blood flow magnitude;

for each modified model of the plurality of modified models:

(a) simulating, non-invasively, ( 1 ) a respective first patient-specific blood flow magnitude indicating a first amount of blood flow at a first location of the patient's vasculature corresponding to the predetermined first location of the population-based reference vasculature, and ( 2 ) a respective second patient-specific blood flow magnitude indicating a second amount of blood flow at a second location of the patient's vasculature corresponding to the predetermined first location of the population-based reference vasculature;

(b) determining a respective patient-specific relative blood flow magnitude by comparing the respective first patient-specific blood flow magnitude to the respective second patient-specific blood flow magnitude; and

(c) determining whether the respective proposed treatment induces vascular steal by determining a difference or ratio between the reference relative blood flow magnitude and the respective patient-specific relative blood flow magnitude; and

based on the determination of whether each of the respective proposed treatments induces vascular steal, providing a recommendation of at least one proposed treatment of the plurality of proposed treatments.

2. The computer-implemented method of claim 1 , further comprising:

receiving a physiological state associated with the patient;

receiving the reference relative blood flow magnitude based on the physiological state; and

for each of modified model of the plurality of modified models, determining the respective patient-specific relative blood flow magnitude based on the physiological state.

3. The computer-implemented method of claim 1 , wherein the respective proposed treatment for at least one of the plurality of modified models includes a vascular geometry different from a geometry of the patient's vasculature or a physiological state different from the physiological state at which the respective first patient-specific relative blood flow magnitude is determined.

4. The computer-implemented method of claim 1 , wherein at least one proposed treatment of the plurality of proposed treatments includes a stent.

5. The computer-implemented method of claim 1 , wherein the respective proposed treatment for at least one modified model of the plurality of modified models includes adding one or more additional branches of a portion of the patient's vasculature.

6. The computer-implemented method of claim 1 , wherein the respective proposed treatment for at least one modified model of the plurality of modified models includes a bypass graft.

7. The computer-implemented method of claim 1 , wherein providing the recommendation of at least one proposed treatment of the plurality of proposed treatments includes determining which of the respective proposed treatments has a lowest likelihood of inducing vascular steal.

8. A system for determining blood flow deviation in a patient's vasculature, the system comprising:

at least one data storage device storing instructions for determining blood flow deviation in a patient's vasculature; and

at least one processor configured to execute the instructions to perform operations including:

receiving a patient-specific anatomic model of at least a portion of a patient's vasculature;

modifying the patient-specific anatomic model to create a plurality of modified models, wherein each of the plurality of modified models includes a respective proposed treatment of a plurality of proposed treatments for a condition other than vascular steal syndrome;

receiving (1) a first reference blood flow magnitude indicating an amount of blood flow at a predetermined first location of a population-based reference vasculature, and (2) a second reference blood flow magnitude indicating an amount of blood flow at a predetermined second location of the population-based reference vasculature;

calculating a reference relative blood flow magnitude by comparing the first reference blood flow magnitude to the second reference blood flow magnitude;

for each modified model of the plurality of modified models:

(a) simulating, non-invasively, (1) a respective first patient-specific blood flow magnitude indicating a first amount of blood flow at a first location of the patient's vasculature corresponding to the predetermined first location of the population-based reference vasculature, and (2) a respective second patient-specific blood flow magnitude indicating a second amount of blood flow at a second location of the patient's vasculature corresponding to the predetermined first location of the population-based reference vasculature;

(b) determining a respective patient-specific relative blood flow magnitude by comparing the respective first patient-specific blood flow magnitude to the respective second patient-specific blood flow magnitude; and

(c) determining whether the respective proposed treatment induces vascular steal by determining a difference or ratio between the reference relative blood flow magnitude and the respective patient-specific relative blood flow magnitude; and

based on the determination of whether each of the respective proposed treatments induces vascular steal, providing a recommendation of at least one of proposed treatment of the plurality of proposed treatments.

9. The system of claim 8 , the operations further comprising:

receiving a physiological state associated with the patient;

receiving the reference relative blood flow magnitude based on the physiological state; and

for each of modified model of the plurality of modified models, determining the respective patient-specific relative blood flow magnitude based on the physiological state.

10. The system of claim 8 , wherein the proposed treatment for at least one model of the plurality of modified models includes a vascular geometry different from a geometry of the patient's vasculature or a physiological state different from the physiological state at which the respective first patient-specific relative blood flow magnitude is determined.

11. The system of claim 8 , wherein at least one proposed treatment of the plurality of proposed treatments includes a stent.

12. The system of claim 8 , wherein the respective proposed treatment for at least one modified model of the plurality of modified models includes adding one or more additional branches of a portion of the patient's vasculature.

13. The system of claim 8 , wherein the respective proposed treatment for at least one modified model of the plurality of modified models includes a bypass graft.

14. The system of claim 8 , wherein providing the recommendation of at least one proposed treatment of the plurality of proposed treatments includes determining which of the respective proposed treatments has a lowest likelihood of inducing vascular steal.

15. A non-transitory computer readable medium for use on a computer system containing computer-executable programming instructions for performing operations determining blood flow deviation in a patient's vasculature, the operations comprising:

receiving a patient-specific anatomic model of at least a portion of a patient's vasculature;

modifying the patient-specific anatomic model to create a plurality of modified models, wherein each of the plurality of modified models includes a respective proposed treatment of a plurality of proposed treatments for a condition other than vascular steal syndrome;

receiving (1) a first reference blood flow magnitude indicating an amount of blood flow at a predetermined first location of a population-based reference vasculature, and (2) a second reference blood flow magnitude indicating an amount of blood flow at a predetermined second location of the population-based reference vasculature;

calculating a reference relative blood flow magnitude by comparing the first reference blood flow magnitude to the second reference blood flow magnitude;

for each modified model of the plurality of modified models:

(a) simulating, non-invasively, (1) a respective first patient-specific blood flow magnitude indicating a first amount of blood flow at a first location of the patient's vasculature corresponding to the predetermined first location of the population-based reference vasculature, and (2) a respective second patient-specific blood flow magnitude indicating a second amount of blood flow at a second location of the patient's vasculature corresponding to the predetermined first location of the population-based reference vasculature;

(b) determining a respective patient-specific relative blood flow magnitude by comparing the respective first patient-specific blood flow magnitude to the respective second patient-specific blood flow magnitude; and

(c) determining whether the respective proposed treatment induces vascular steal by determining a difference or ratio between the reference relative blood flow magnitude and the respective patient-specific relative blood flow magnitude; and

based on the determination of whether each of the respective proposed treatments induces vascular steal, providing a recommendation of at least one of proposed treatment of the plurality of proposed treatments.

16. The non-transitory computer readable medium of claim 15 , the operations further comprising:

receiving a physiological state associated with the patient;

receiving the reference relative blood flow magnitude based on the physiological state; and

for each of modified model of the plurality of modified models, determining the respective patient-specific relative blood flow magnitude based on the physiological state.

17. The non-transitory computer readable medium of claim 16 , wherein the proposed treatment for at least one model of the plurality of modified models includes a vascular geometry different from a geometry of the patient's vasculature or a physiological state different from the physiological state at which the respective first patient-specific relative blood flow magnitude is determined.

18. The non-transitory computer readable medium of claim 15 , wherein at least one proposed treatment of the plurality of proposed treatments includes a stent.

19. The non-transitory computer readable medium of claim 15 , wherein the respective proposed treatment for at least one modified model of the plurality of modified models includes adding one or more additional branches of a portion of the patient's vasculature.

20. The non-transitory computer readable medium of claim 15 , wherein the respective proposed treatment for at least one modified model of the plurality of modified models includes a bypass graft.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2025
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 072876/0775 →
SECURITY INTEREST Recorded Jun 18, 2024
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 067775/0966 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2021
From: GRADY, LEO J.; TAYLOR, CHARLES A.
To: HEARTFLOW, INC.
Reel/Frame 055840/0765 →
Continuity (3)
Continuation 14691105 · Apr 20, 2015
Provisional Application 62110817 · Feb 2, 2015
Related Publication 20210228094A1 · Jul 29, 2021
Cited By (27)
US 12,245,882 US 12,283,046 US 12,299,885 US 12,315,076 US 12,324,695 US 12,324,696 US 12,354,755 US 12,380,560 US 12,387,325 US 12,396,695 US 12,406,365 US 12,408,885 US 12,423,813 US 12,440,180 US 12,446,965 US 12,499,539 US 12,499,646 US 12,512,196 US 12,531,159 US 12,555,228 US 12,558,048 US 12,567,489 US 12,599,352 US 12,620,092 US 12,635,965 US 12,712,082 US 12,714,382